Literature DB >> 20933028

Sulfated cholecystokinin-8 activates phospho-mTOR immunoreactive neurons of the paraventricular nucleus in rats.

Vanessa Lembke1, Miriam Goebel2, Lisa Frommelt1, Tobias Inhoff3, Reinhardt Lommel1, Andreas Stengel1,2, Yvette Taché2, Carsten Grötzinger3, Norbert Bannert4, Bertram Wiedenmann3, Burghard F Klapp1, Peter Kobelt1,3.   

Abstract

The serin/threonin-kinase, mammalian target of rapamycin (mTOR) was detected in the arcuate nucleus (ARC) and paraventricular nucleus of the hypothalamus (PVN) and suggested to play a role in the integration of satiety signals. Since cholecystokinin (CCK) plays a role in the short-term inhibition of food intake and induces c-Fos in PVN neurons, the aim was to determine whether intraperitoneally injected CCK-8S affects the neuronal activity in cells immunoreactive for phospho-mTOR in the PVN. Ad libitum fed male Sprague-Dawley rats received 6 or 10 μg/kg CCK-8S or 0.15M NaCl ip (n=4/group). The number of c-Fos-immunoreactive (ir) neurons was assessed in the PVN, ARC and in the nucleus of the solitary tract (NTS). CCK-8S increased the number of c-Fos-ir neurons in the PVN (6 μg: 103 ± 13 vs. 10 μg: 165 ± 14 neurons/section; p<0.05) compared to vehicle treated rats (4 ± 1, p<0.05), but not in the ARC. CCK-8S also dose-dependently increased the number of c-Fos neurons in the NTS. Staining for phospho-mTOR and c-Fos in the PVN showed a dose-dependent increase of activated phospho-mTOR neurons (17 ± 3 vs. 38 ± 2 neurons/section; p<0.05), while no activated phospho-mTOR neurons were observed in the vehicle group. Triple staining in the PVN showed activation of phospho-mTOR neurons co-localized with oxytocin, corresponding to 9.8 ± 3.6% and 19.5 ± 3.3% of oxytocin neurons respectively. Our observations indicate that peripheral CCK-8S activates phospho-mTOR neurons in the PVN and suggest that phospho-mTOR plays a role in the mediation of CCK-8S's anorexigenic effects.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20933028      PMCID: PMC4040259          DOI: 10.1016/j.peptides.2010.09.025

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  36 in total

1.  Involvement of medullary catecholamine cells in neuroendocrine responses to systemic cholecystokinin.

Authors:  K M Buller; T A Day
Journal:  J Neuroendocrinol       Date:  1996-11       Impact factor: 3.627

2.  Oxytocin and an oxytocin agonist administered centrally decrease food intake in rats.

Authors:  B R Olson; M D Drutarosky; M S Chow; V J Hruby; E M Stricker; J G Verbalis
Journal:  Peptides       Date:  1991 Jan-Feb       Impact factor: 3.750

3.  Brain oxytocin receptor antagonism blunts the effects of anorexigenic treatments in rats: evidence for central oxytocin inhibition of food intake.

Authors:  B R Olson; M D Drutarosky; E M Stricker; J G Verbalis
Journal:  Endocrinology       Date:  1991-08       Impact factor: 4.736

4.  Synergistic interaction between leptin and cholecystokinin to reduce short-term food intake in lean mice.

Authors:  M D Barrachina; V Martínez; L Wang; J Y Wei; Y Taché
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-16       Impact factor: 11.205

5.  Oxytocin inhibits food and fluid intake in rats.

Authors:  R Arletti; A Benelli; A Bertolini
Journal:  Physiol Behav       Date:  1990-12

6.  Identification of nesfatin-1 as a satiety molecule in the hypothalamus.

Authors:  Shinsuke Oh-I; Hiroyuki Shimizu; Tetsurou Satoh; Shuichi Okada; Sachika Adachi; Kinji Inoue; Hiroshi Eguchi; Masanori Yamamoto; Toshihiro Imaki; Koushi Hashimoto; Takafumi Tsuchiya; Tsuyoshi Monden; Kazuhiko Horiguchi; Masanobu Yamada; Masatomo Mori
Journal:  Nature       Date:  2006-10-01       Impact factor: 49.962

7.  Hypothalamic mTOR signaling regulates food intake.

Authors:  Daniela Cota; Karine Proulx; Kathi A Blake Smith; Sara C Kozma; George Thomas; Stephen C Woods; Randy J Seeley
Journal:  Science       Date:  2006-05-12       Impact factor: 47.728

8.  Capsaicin pretreatment attenuates suppression of food intake by cholecystokinin.

Authors:  R C Ritter; E E Ladenheim
Journal:  Am J Physiol       Date:  1985-04

9.  Behavioral effects of corticotropin-releasing factor: localization and characterization of central effects.

Authors:  D D Krahn; B A Gosnell; A S Levine; J E Morley
Journal:  Brain Res       Date:  1988-03-08       Impact factor: 3.252

10.  Central nesfatin-1 reduces dark-phase food intake and gastric emptying in rats: differential role of corticotropin-releasing factor2 receptor.

Authors:  Andreas Stengel; Miriam Goebel; Lixin Wang; Jean Rivier; Peter Kobelt; Hubert Mönnikes; Nils W G Lambrecht; Yvette Taché
Journal:  Endocrinology       Date:  2009-10-01       Impact factor: 4.736

View more
  1 in total

Review 1.  mTOR and regulation of energy homeostasis in humans.

Authors:  Marwan Mannaa; Stephanie Krämer; Michael Boschmann; Maik Gollasch
Journal:  J Mol Med (Berl)       Date:  2013-06-12       Impact factor: 4.599

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.